1. Home
  2. CHGG vs STIM Comparison

CHGG vs STIM Comparison

Compare CHGG & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chegg Inc.

CHGG

Chegg Inc.

HOLD

Current Price

$1.03

Market Cap

117.4M

Sector

Real Estate

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.20

Market Cap

140.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHGG
STIM
Founded
2005
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.4M
140.6M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
CHGG
STIM
Price
$1.03
$1.20
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
2.4M
2.5M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
88.15
57.25
EPS
N/A
N/A
Revenue
$376,908,000.00
$52,776,000.00
Revenue This Year
N/A
$11.10
Revenue Next Year
N/A
$11.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$0.80
52 Week High
$1.89
$4.84

Technical Indicators

Market Signals
Indicator
CHGG
STIM
Relative Strength Index (RSI) 50.21 37.93
Support Level $0.87 $0.80
Resistance Level $1.26 $1.55
Average True Range (ATR) 0.13 0.22
MACD -0.03 -0.08
Stochastic Oscillator 26.57 0.38

Price Performance

Historical Comparison
CHGG
STIM

About CHGG Chegg Inc.

Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Chegg Skilling; and Academic Services, which derives maximum revenue. Geographically, it derives in United States and International.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: